Trilogy International Partners Inc T.TRL.WT.A

RE:RE:Anyone watching this?

[WCoyote]

We have a lot of the world covered now with licences agreements.  The more the better, but I think the real catalyst is going to be money.  Folks will begin to smell that when Natesto licensees get approved as that will mean orders to stock initial launches.

Of course, the US partner is doing very well with Natesto sales and this will begin showing well beginning with the yearend financials in early March (our next scheduled touch point).  That will be an interesting conference call.  The Canadian Natesto revenue will be ramping up as well going forward.  As the other Licensees come on line we should be seeing real revenue flowing by mid-2019.

Money and licensees getting approved and launched are the stars of the show, but catalysts in supporting roles include:

More licenses
Launch of UriVarx
Approval of Gynoflor
Launch of Gynoflor
Submission of Elegant application
Approval of Elegant
Launch of Elegant